Sign in
4

Changes in Ownership

DNA X, Inc. Filed Acc 0001493152-22-033223

Options or other derivatives

  • Chief Executive Officer acquired 4,014,419 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Liu Hao Peter Chief Executive Officer 2022-11-18 Grant or award · Employee Stock Option (Right-to-Buy) +4,014,419 4,014,419 D
Loading xslF345X03/ownership.xml…